Litigation Details for Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2022)
✉ Email this page to a colleague
Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-07-08 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 9,763,933; 9,775,808 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharma L.P. v. Accord Healthcare Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-09-08 | 78 | Order - Memorandum and Order AND ~Util - Terminate Motions | the ’908 and ’909 patents, including U.S. Patent Nos. 9,763,933 (“the ’933 patent”); 9,775,808 (“the ’808…infringement of U.S. Patent Nos. 11,304,908 (“the ’908 patent”) and 11,304,909 (“the ’909 patent”). Accord has…claim 3 of the ’933 patent, claim 3 of the ’808 patent, and claim 6 of the ’886 patent against Accord. In….” ’908 patent, Abstract. As Purdue explains in its brief, the object of the asserted patents is to make…other within the matrix. ’908 patent, cl. 1 Purdue owns other patents in the same family as the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
